Alexis Du Peloux
Partner @ XAnge
Paris, France
Alexis Du Peloux is a seed investor at XAnge in Paris focused on Cyber Security and Artificial Intelligence. Alexis Du Peloux - Partner @ XAnge
- Total investments:
- 9
- Last investment:
- Lead investor:
- 44%
Last updated:
For AI agents: llms.txt
Industries Alexis Du Peloux invests in
Stages Alexis Du Peloux invests in
Countries Alexis Du Peloux invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Cyber Security 2 (22%)
- Artificial Intelligence 2 (22%)
- SaaS 1 (11%)
- FinTech 1 (11%)
- Software 1 (11%)
Stage
- Seed 4 (44%)
- Series A 2 (22%)
- Pre-Seed 1 (11%)
- Series B 1 (11%)
- Venture - Series Unknown 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tomorro is an AI-driven contract lifecycle management platform that automates the processes of contract creation, negotiation, and approval. The platform streamlines workflows for sales teams by providing tools that enhance efficiency and accuracy in contract management. It offers features such as automated document generation, real-timecollaboration, and built-in compliance checks. Tomorro also includes an e-signature solution that facilitates the signing of contracts, ensuring a seamless experience for users. By integrating these functionalities, Tomorro aims to simplify the complexities of contract management for organizations. | $27M / Series B / Mar 31, 2025 | ||
| Request Finance provides a financial management platform for businesses to handle cryptocurrency invoicing, payroll, and expenses. The platform enables users to send and receive invoices in various cryptocurrencies, automate payments, and track financial transactions. It supports compliance with tax regulations and integrates with accountingsystems for streamlined reporting. Request Finance serves companies, freelancers, and DAOs by simplifying digital asset payments and financial operations. | Venture - Series Unknown / Mar 25, 2025 | ||
| 1 stop shop AI API hub for developers | $15.9M / Series A / Oct 15, 2024 | ||
| Dattak offers cyber insurance solutions based on cybersecurity technologies. Their cybersecurity tools allow us to assess a company's level of cybersecurity without complex questionnaires. They provide their policyholders with a variety of cybersecurity tools to help them prevent and defend against cyberattacks. | $12M / Series A / Aug 30, 2023 | ||
| Elba interfaces with the SaaS ecosystem of its customers, finds security flaws, and alerts their teams to repair them with a single click. | $2.7M / Seed / Jun 06, 2023 | ||
| Dogami is a mass-market NFT play-to-earn game that is centered around 3D NFT dog avatars. | $7M / Seed / Dec 13, 2022 | ||
| Request Finance provides a financial management platform for businesses to handle cryptocurrency invoicing, payroll, and expenses. The platform enables users to send and receive invoices in various cryptocurrencies, automate payments, and track financial transactions. It supports compliance with tax regulations and integrates with accountingsystems for streamlined reporting. Request Finance serves companies, freelancers, and DAOs by simplifying digital asset payments and financial operations. | $5.5M / Seed / Jun 08, 2022 | ||
| Roof creates better housing solutions by designing and managing furnished, community-minded quality homes located in Top Student Cities. | $3.4M / Pre-Seed / Jan 01, 2022 | ||
| Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion.The Epigene Labstechnology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches.With R&D in Paris and business development in Boston, Epigene Labs operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs. | $1.5M / Seed / Jan 30, 2020 |
Co-Investors
About XAnge
XAnge is a BCorp-certified early-stage investment fund managing €700 million, with offices in Paris, Berlin, and Brussels. The fund backs European founders who aim to transform daily life through technology, investing between €500,000 and €10 million from the seed stage onwards. XAnge’s investment focus spans deeptech, health, fintech, SaaS, and e-commerce, with a portfolio including Lydia, Welcome to the Jungle, Believe, MrSpex, and Ledger. XAnge is the innovation-driven venture capital brand of the Siparex Group.
XAnge Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alexis Du Peloux
Partner
|
|||
Cyril Bertrand
CEO & Managing Partner
|
|||
Guilhem De Vregille
Partner
|
|||
Andréas Gall
Partner
|
|||
Astrid Moullé-Berteaux
Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alexis Du Peloux invest in?
Alexis Du Peloux invests primarily in Cyber Security, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alexis Du Peloux?
Public channels for Alexis Du Peloux include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alexis Du Peloux last invest?
The most recent investment recorded for Alexis Du Peloux closed in Mar 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
